ACTRN12609000891224尚未招募1 期
Phase 1 Randomized, Double-Blind, Placebo-Controlled Trial in Healthy Male Volunteers To Examine The Safety, Tolerability, And Pharmacokinetics Of HMPL-011 After A Single Dose
Hutchison MediPharma0 个研究点目标入组 32 人开始时间: 2009年10月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 45 Years（—）
- 性别
- Male
入选标准
- •Healthy male subjects having Body Mass Index(BMI) between 19 and 34 kg/m2
排除标准
- •Any significant acute or chronic medical conditions. Subjects at risk of tuberculosis(TB). Evidence of organ dysfunction or any clinically significant deviation from normal.
研究者
相似试验
已完成
1 期
A study to investigate how ENTR-601-44 behaves in the body, the safety and how well tolerated different increasing amounts of the drug ENTR-601-44 are when given to healthy male volunteersHealthy volunteersISRCTN36174912Entrada Therapeutics, Inc.32
招募中
1 期
A Phase 1 Study of MAXONA Pharmaceuticals MAX-001 healthy subjects for the evaluation of safety, tolerability, and drug concentrations in progressively increasing single and multiple daily dose levelsVarious pain indicationsAnaesthesiology - Pain managementACTRN12622001351707George Clinical Pty Ltd60
尚未招募
1 期
A study to evaluate the safety, tolerability, and pharmacokinetics of a single dose of the drug F-652 in healthy male volunteers.Alcoholic HepatitisInflammatory and Immune System - Other inflammatory or immune system disordersOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12612000713897Generon Corporation Ltd40
已完成
1 期
A study to evaluate the safety and pharmacokinetics of DB-020 when administered to healthy participantsOtotoxicityEar - DeafnessACTRN12618001710213Decibel Therapeutics Australia Pty Ltd42
尚未招募
1 期
Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RPH-203 Following a Single Dose in Healthy Male VolunteersBone MetastasisCancer - BoneMusculoskeletal - OsteoporosisOsteoporosisACTRN12613000651785ucleus Network Limited48